Expression of ESBL, MBL and AmpC β lactamases by extra intestinal Escherichia coli isolates: correlation with treatment and clinical outcome

Journal Title: Journal of Microbiology and Infectious Diseases - Year 2013, Vol 3, Issue 4

Abstract

Objective: We investigated the expression of Extended Spectrum β-Lactamases (ESBLs), AmpC β lactamases and Carbapenemases in extraintestinal pathogenic Escherichia coli (ExPEC) isolates and correlated with treatment and outcome of the patients. Methods: Three hundred ExPEC infected patients were included in the study. Demographic data, antibiogram, treatment and outcome were collected. Production of ESBLs was detected by combination disk method; AmpC was detected by AmpC disk test. Carbapenemase production was detected by disk diffusion and confirmed by modified Hodge test. Identification of metallo- β-lactamase (MBL) activity was performed by the carbapenem-EDTA combined disk method and MBL E-test. Results: Out of 300 E. coli isolates, 212 (71%) were ESBL producers. AmpC β lactamase production was seen in 95 (32%) isolates; 16 (17%) isolates were pure AmpC producers whereas 79 (83%) were ESBL co-producers. Twenty nine (9.5%) isolates were carbapenemase producers of which 15 (5%) were MBL producers. For treatment, most widely prescribed antibiotics were β-lactam+β-lactamase inhibitor combinations (39%). Sixty seven percent patients improved; relapse/re-infection was seen in 18% of patients and 11% patients expired. Increased mortality was seen in patients with blood stream infection and more number of relapses was seen in urinary tract infection. Conclusion: ExPEC producing ESBL or AmpC along with carbapenemases are particularly challenging for clinicians and are a major threat worldwide. Early use of appropriate antibiotics like β-lactam+β-lactamase inhibitor combinations will probably reduce complications in these patients. Key words: AmpC, ExPEC, ESBL, MBL, J Microbiol Infect Dis 2013;3(4): 150-156

Authors and Affiliations

Arindam Chakraborty, Prabha Adhikari, Shalini Shenoy, Shrikala Baliga, Satish Rao, Dhanashree Biranthabail, Vishwas Saralaya

Keywords

Related Articles

Orta Doğu Solunum Sendromu: MERS

Orta Doğu Solunum Sendromu: MERSOrta Doğu Solunum Sendromu coronovirüsü (MERS-CoV) yeni ortaya çıkan bir solunum virüsüdür. Bu virus ilk olarak 2012 yılında Suudi Arabistan’da tanımlanmıştır. Orta Doğu solunum sendromu k...

A rare cause of soft tissue infections: Pseudallescheria boydii

Pseudallescheria boydii, a rare cause of infection in humans, are saprofitic microorganisms which are found in soil. In this report, we describe a renal transplant patient who had a skin-soft tissue infection at the ante...

Hepatitis B and C Seroprevalence in Leprosy Patients 

Objective: Leprosy is a contagious chronic granulomatous disease and commonly affects the eyes and the internal organs. Leprosy can be classified according to the level of immune response. Leprosy is a disease that...

Extended Spectrum β-lactamases and antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa in the West Bank, Palestine

Objectives: Class D oxacillinases are frequently acquired by gram negative bacteria in general and P. aeruginosa in particular. P. aeruginosa is commonly implicated in causing nosocomial infections. The evolution of ant...

Kırım-Kongo Hemorajik Ateşli Hastalarda Ortalama Trombosit Hacmi ve ötrofil/Lenfosit Oranının Prognostik Değeri

Amaç: Kırım-Kongo Kanamalı Ateşi (KKHA) virüsü, Bunyaviridae ailesine üye Nairovirus olup insanlarda ciddi hastalığa neden olur. KKKA enfeksiyonunda pansitopeni, organ yetersizliği ve yaygın damar-içi pıhtılaşma ortaya ç...

Download PDF file
  • EP ID EP151931
  • DOI 10.5799/ahinjs.02.2013.04.0100
  • Views 80
  • Downloads 0

How To Cite

Arindam Chakraborty, Prabha Adhikari, Shalini Shenoy, Shrikala Baliga, Satish Rao, Dhanashree Biranthabail, Vishwas Saralaya (2013). Expression of ESBL, MBL and AmpC β lactamases by extra intestinal Escherichia coli isolates: correlation with treatment and clinical outcome. Journal of Microbiology and Infectious Diseases, 3(4), 150-156. https://europub.co.uk/articles/-A-151931